Pancreatic Cyst clinical trials at UCLA
2 research studies open to eligible people
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
open to eligible people ages 50-75
The purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers. The study doctors want to compare more frequent monitoring versus less frequent monitoring as well as identify biomarkers which may improve risk detection of transformation to pancreatic cancer. The study doctors want to learn which monitoring method and which biomarkers lead to better outcomes for patients.
Los Angeles, California and other locations
Pancreatic Cancer Early Detection Consortium
open to eligible people ages 18-90
The purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal adenocarcinoma (PDAC) by establishing a multisite cohort of individuals with family history of PDAC and/or individuals carrying pathogenic/likely pathogenic germline variants (PGVs) in genes linked to PDAC risk for longitudinal follow up.
Los Angeles, California and other locations
Our lead scientists for Pancreatic Cyst research studies include Timothy R. Donahue.
Last updated: